Endo Inc.

11/18/2024 | Press release | Distributed by Public on 11/18/2024 16:55

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling